HYGIEIA. REFORMING INSULIN THERAPY AS WE KNOW IT.

We are Hygieia. And we are singularly focused on revolutionizing how people manage their insulin. Using science, research and technology, we developed a breakthrough and highly effective insulin management program that not only changes how patients and physicians manage insulin today, but also establishes the standard of autonomous insulin dose adjustment.
With over seven million Americans with type 2 diabetes using insulin and only 33% achieving successful results, the need for a monumental shift in insulin management has never been greater. Hygieia’s founders, Dr. Eran Bashan and Dr. Israel Hodish answer the call with d-Nav Technology2 — an FDA-cleared breakthrough insulin management tool designed to significantly improve and simplify insulin treatment so that more people who are on insulin therapy succeed.
From inception, it has been our mission to redefine the way the world manages insulin, and we are committed to leading the charge.
MANAGEMENT TEAM

Eran Bashan, PhD
CEO & Chairman of the Board

Israel Hodish, MD, PhD
Co-founder & Medical Director

Mark Willis
Chief Technology Officer

Donna McCollum
Vice President of Research & Development

Steve Calef
Vice President of Finance

Gilad Lederer
Head of International Business Development
BOARD OF DIRECTORS

John Brooks
Board Member

Mark Hirschhorn
Board Member

Charles Bisgaier
Board Member

Nir Tarlovsky
Board Member
ADVISORY BOARD

Richard M. Bergenstal, MD

George Grunberger, MD

Mark Fendrick, MD

Michael J. Miller, MD

Karen Drexler
NEWS
Discover important news about d-Nav and type 2 diabetes.
CONTACT
Let us know if
we can help.